The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes

Area of Science:

• Endocrinology
• Metabolic Diseases
• Immunology

Background:

• Blood glucose regulation involves beta cells secreting insulin and insulin-sensitive tissues responding.
• Dysregulation stems from beta-cell failure, insulin resistance, or both.
• Traditional distinctions between Type I and Type II diabetes are blurring, with beta-cell insufficiency a common factor.

Purpose of the Study:

• To present the 'Accelerator Hypothesis' unifying the understanding of Type I and Type II diabetes.
• To highlight the central role of excess weight gain in diabetes development and rising incidence.
• To propose weight management as a strategy for diabetes prevention and control.

Main Methods:

• Conceptual framework presentation (The 'Accelerator Hypothesis').
• Analysis of the interplay between weight gain, insulin resistance, and beta-cell apoptosis.
• Integration of clinical and etiological factors for both diabetes types.

Main Results:

• Excess weight gain is identified as a prerequisite for diabetes development, irrespective of type.
• Weight gain exacerbates insulin resistance, leading to impaired glucose control.
• Glucotoxicity and autoimmunity, accelerated by weight gain, drive beta-cell apoptosis.

Conclusions:

• The 'Accelerator Hypothesis' posits an 'overlay' rather than 'overlap' between diabetes types, with body mass as the central element.
• Weight gain, insulin resistance, and beta-cell apoptosis are interconnected drivers of diabetes.
• Controlling weight gain and insulin resistance offers a primary strategy for minimizing diabetes incidence and severity.